Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerate

Current leaders Eli Lilly and Novo Nordisk have cornered the early market for weight loss therapeutics, but several other players, large and small, are bidding for a piece of the potential $200 billion pie.